Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Prediction of antibody persistency from antibody titres to natalizumab.
Determinants of disability using count-based approaches to icf-based definition of neurological disability.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Developing a therapeutic plan for treating MS: evidence for new treatments.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
[Multimodal complex treatment in multiple sclerosis : Influence on motor performance and need of care.]
Pages
« first
‹ previous
…
267
268
269
270
271
272
273
274
275
…
next ›
last »